Rational design synthesis and evaluation of a novel near-infrared fluorescent probe for selective imaging of amyloid-β aggregates in Alzheimer's disease

Alzheimer's disease (AD) is a degenerative neurological disorder that remains incurable to date, seriously affecting the quality of life and health of those affected. One of the key neuropathological hallmarks of AD is the formation of amyloid-beta (A beta) plaques. Near-infrared (NIR) probes that possess a large Stokes shift show great potential for imaging of A beta plaques in vivo and in vitro. Herein, we proposed a rational strategy for design and synthesis of a series of NIR fluorescent probes that incorporate a tricarbonitrile group as a strong electron-withdrawing group (EWG) to enable NIR emission and large Stokes shift for optimal imaging of A beta plaques. The probe TCM-UM exhibited remarkable in vitro performance, including strong NIR emission (lambda(em) = 670 nm), large Stokes shift (120-245 nm), and its affinity for A beta(42) aggregates (K-d = 43.78 +/- 4.09 nM) was superior to the commercially available probe Thioflavin T (ThT, K-d = 896.04 +/- 33.43 nM). Further, TCM-UM was selected for imaging A beta plaques in brain tissue slices and APP/PS1 transgenic (AD) mice, the results indicated that TCM-UM had an excellent ability to penetrate the blood-brain barrier (BBB) compared with ThT, and it could effectively distinguish wild-type (Wt) mice and APP/PS1 transgenic (AD) mice.